Qlife Holding ABOSTO:QLIFE +1.47%15 Days Payable is 2,972.75 as of Mar. 2026, which is 353% above its 10-year median of 656.19. GuruFocus rates OSTO:QLIFE with a GF Score™ of 15/100 and a GF Value™ of kr0.76 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Qlife Holding AB ranks better than 95.09% on this metric.
The historical rank and industry rank for Qlife Holding AB's Days Payable or its related term are showing as below:
OSTO:QLIFE'
s Days Payable Range Over the Past 10 Years
Min: 191.17 Med: 656.19 Max: 12555.65
Current: 854.77
During the past 7 years, Qlife Holding AB's highest Days Payable was 12555.65. The lowest was 191.17. And the median was 656.19.
OSTO:QLIFE's Days Payable is ranked better than 95.09% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs OSTO:QLIFE: 854.77
Qlife Holding AB's Days Payable
increased
from Mar. 2025 (495.23) to Mar. 2026 (2,972.75).
It may suggest that Qlife Holding ABdelayed paying its suppliers.
Qlife Holding AB Days Payable Related Terms
Qlife Holding AB Days Payable Historical Data
* Premium members only.
The historical data trend for Qlife Holding AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:QLIFE vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Qlife Holding AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qlife Holding AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Qlife Holding AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Qlife Holding AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qlife Holding AB (OSTO:QLIFE) has a Days Payable of 2,972.75 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Qlife Holding AB and its competitors. This is 353% above median its historical median of 656.19. Over the past decade, Qlife Holding AB's Days Payable has ranged from 191.17 to 12,555.65. According to the industry distribution chart, Qlife Holding AB ranks #39 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 4.9%.
Is Qlife Holding AB's Days Payable too high?
Qlife Holding AB's current Days Payable of 2,972.75 is 353% above median its 10-year median of 656.19. Over the past 10 years, this metric has ranged from a low of 191.17 to a high of 12,555.65. The Medical Devices & Instruments industry median Days Payable is 68.07. Qlife Holding AB's value of 2,972.75 is 4267.2% above this industry median. Based on the distribution chart, Qlife Holding AB ranks #39 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Qlife Holding AB has a GF Score™ of 15/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qlife Holding AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Qlife Holding AB ranks #39 out of 795 companies for Days Payable. This places Qlife Holding AB in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Qlife Holding AB's value of 2,972.75 is 4267.2% above this benchmark. Historically, Qlife Holding AB's own Days Payable has ranged from 191.17 to 12,555.65 over the past decade. While the company's 10-year median is 656.19 vs. the industry median of 68.07, Qlife Holding AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qlife Holding AB's current Days Payable of 2,972.75 is 4267.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Qlife Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qlife Holding AB's current Days Payable is 2,972.75, which is 353% above median its own 10-year median of 656.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qlife Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Qlife Holding AB (OSTO:QLIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.76, compared to a current price of kr1.93 — trading 153.9% above its estimated fair value. The current Days Payable is 2,972.75, which is 353% above median its 10-year median of 656.19 and 4267.2% above the Medical Devices & Instruments industry median of 68.07. Qlife Holding AB's overall GF Score™ is 15/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Qlife Holding AB (OSTO:QLIFE), the current Days Payable is 2,972.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qlife Holding AB (OSTO:QLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, Qlife Holding AB stock appears to be overvalued.
The current stock price of kr1.93 is trading 153.9% above its estimated GF Value™ of kr0.76.
GuruFocus considers Qlife Holding AB to be Significantly Overvalued.
Key valuation signals for OSTO:QLIFE:
Days Payable: 2,972.75 (353% above median its 10-year median of 656.19)
GF Value™: kr0.76 vs. price of kr1.93 (153.9% above fair value)
Industry Position: 4267.2% above the Medical Devices & Instruments median (#39 of 795)
No single metric tells the full story. See the OSTO:QLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
15GF Score
Get the complete analysis for OSTO:QLIFE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:QLIFE has been successfully added to your 
